This federal contract award, valued at $4,647.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to support military treatment programs and facilities. The award has an ultimate completion date of September 30, 2024, and is a Firm Fixed Price Delivery Order contract. There is no set-aside designation mentioned in the information provided....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The $4,647.12 Firm Fixed Price delivery order does not have a set-aside designation and has an ultimate completion date of August 19, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $4,647.12 firm-fixed-price contract provides for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of medications, medical supplies, and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $19,997.68 firm fixed-price contract is for the delivery of 4,565,860,590 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has an ultimate completion date of September 19, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded numerous...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $8,667.31 firm-fixed-price delivery order is for the supply of 4,565,351,716 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has an ultimate completion date of August 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $14,247.02 firm fixed price contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract has an ultimate completion date of August 27, 2024. Amerisourcebergen is a large pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of essential medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products. The delivery order has a ceiling value of $3,872.60 and is a firm fixed-price contract with a period of performance through July 2024. This award is not set aside for any specific business type. As a large pharmaceutical company, AmerisourceBergen has been awarded numerous federal contracts...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $4,647.12 firm-fixed-price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract has an ultimate completion date of August 19, 2024 and was awarded on August 16, 2024. Amerisourcebergen, a major pharmaceutical distributor in the United States, has been awarded...
This federal contract award, valued at $4,876.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of September 19, 2024 and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. As a supplier to various government agencies, Amerisourcebergen holds several...
This federal contract award, valued at $10,153.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a completion date of September 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with any set-aside designation, indicating open competition....